AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Switglim-M 4mg/1000mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Akumentis Healthcare Ltd

Salt Composition

Glimepiride (4mg) + Metformin (1000mg)

Overview Switglim-M 4mg/1000mg Tablet PR

Diabex Duo 4mg/1000mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This dual-action formula helps regulate blood glucose. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication complements a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle adjustments are essential for effective diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary foods, juice) are vital. Alcohol consumption should be minimized due to its hypoglycemic risk. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests assessing blood cell counts and liver function, are recommended.

Primary Ingredients of Switglim-M 4mg/1000mg Tablet PR

No text provided. Please provide the text you want me to rephrase.

Uses of Switglim-M 4mg/1000mg Tablet PR

Managing type 2 diabetes

Major Benefits of Switglim-M 4mg/1000mg Tablet PR:

Follow your doctor's instructions or refer to the product label for usage guidance. Consume Switglim-M 4mg/1000mg Tablet PR with a meal.

Common Side effects of Switglim-M 4mg/1000mg Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Switglim-M 4mg/1000mg Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Administer Switglim-M 4mg/1000mg Tablet PR with a meal.

How Switglim-M 4mg/1000mg Tablet PR works:

Switglim-M 4mg/1000mg tablets contain Glimepiride and Metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to produce more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose output, slowing intestinal glucose uptake, and enhancing the body's response to insulin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption with Switglim-M 4mg/1000mg PR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Switglim-M 4mg/1000mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Lactation and the use of Switglim-M 4mg/1000mg tablets are incompatible due to potential infant toxicity indicated by available data.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Switglim-M 4mg/1000mg Tablet PR cautiously, potentially requiring dosage modification. Consult your physician for guidance. Switglim-M 4mg/1000mg Tablet PR is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should exercise caution when using Switglim-M 4mg/1000mg Tablet PR. Dosage modification of Switglim-M 4mg/1000mg Tablet PR may be necessary. Medical advice is recommended. A low initial dose of Switglim-M 4mg/1000mg Tablet PR is typically prescribed for patients with mild to moderate liver disease; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Switglim-M 4mg/1000mg Tablet PR :

Should you forget to take a Switglim-M 4mg/1000mg PR tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Switglim-M 4mg/1000mg Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Switglim-M 4mg/1000mg Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Switglim-M 4mg/1000mg Tablet PR can cause lactic acidosis, a serious medical emergency involving excess blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Switglim-M 4mg/1000mg Tablet PR and seek immediate medical attention.
Switglim-M 4mg/1000mg tablets are a combined Glimepiride and Metformin treatment for type 2 diabetes mellitus in adults. This medication improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while Metformin reduces liver glucose production and enhances insulin sensitivity. It is unsuitable for type 1 diabetes.
Switglim-M 4mg/1000mg Tablet PR may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Switglim-M 4mg/1000mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some researchers.
Switglim-M 4mg/1000mg tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Switglim-M 4mg/1000mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Switglim-M 4mg/1000mg Tab...
123
MRP 143
13% off